Literature DB >> 17164030

Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.

E Dierckx1, S Engelborghs, R De Raedt, P P De Deyn, I Ponjaert-Kristoffersen.   

Abstract

BACKGROUND: Discriminating Alzheimer's disease (AD) and mild cognitive impairment (MCI) from depression is a challenge in psychogeriatric medicine. A study was set up to ascertain whether cued recall could be useful in differentiating early AD and MCI from depression among elderly individuals.
METHOD: The Visual Association Test (VAT) and the Memory Impairment Screen-plus (MIS-plus) were administered together with the Mini-Mental State Examination (MMSE) and the Geriatric Depression Scale (GDS) to 40 MCI patients, 35 mild AD patients, 46 depressed patients and 52 healthy control subjects.
RESULTS: A one-way analysis of variance (ANOVA) followed by post-hoc Scheffé tests showed that AD patients had significantly lower cued recall scores (i.e. combined VAT and MIS-plus scores) than MCI patients, who in turn had lower scores than depressed patients. The scores of depressed patients and controls were not significantly different. Discriminant analysis revealed that 94% of the AD patients and 96% of the depressed patients could be classified correctly by means of the GDS and the cued recall sores. Receiver operating characteristic (ROC) curves identified an optimal cut-off score of 8 (maximum score 12) for differentiating AD and MCI patients from depressed elderly patients and controls. Applying this cut-off, a sensitivity of 83% (58%) and a specificity of 85% (85%) was obtained when differentiating AD (MCI) from depression.
CONCLUSIONS: Cued recall, operationalized by the combined scores of VAT and MIS-plus, is a useful method for differentiating AD patients from depressed individuals and healthy controls. Probably because of the great heterogeneity among MCI patients, the diagnostic power of cued recall decreases when applied to differentiate MCI from depression.

Entities:  

Mesh:

Year:  2006        PMID: 17164030     DOI: 10.1017/S003329170600955X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

1.  Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.

Authors:  Kathryn V Papp; Rebecca E Amariglio; Elizabeth C Mormino; Trey Hedden; Maria Dekhytar; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Neuropsychologia       Date:  2015-05-19       Impact factor: 3.139

2.  Neural correlates associated with cognitive decline in late-life depression.

Authors:  Lihong Wang; Guy G Potter; R K Ranga Krishnan; Florin Dolcos; Gwenn S Smith; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2012-08       Impact factor: 4.105

3.  Effect of Worry Level on Recall Memory for Odors in ApoE-ε4 Carriers and Non-Carriers.

Authors:  Emily S Bower; Jacquelyn Szajer; Claire Murphy
Journal:  J Int Neuropsychol Soc       Date:  2019-04-16       Impact factor: 2.892

4.  Visual short-term memory binding in Alzheimer's disease and depression.

Authors:  Mario A Parra; Sharon Abrahams; Robert H Logie; Sergio Della Sala
Journal:  J Neurol       Date:  2010-02-17       Impact factor: 4.849

5.  Alzheimer's disease, but not ageing or depression, affects dual-tasking.

Authors:  Reiner Kaschel; Robert H Logie; Miguel Kazén; Sergio Della Sala
Journal:  J Neurol       Date:  2009-06-19       Impact factor: 4.849

6.  Early diagnosis of mild cognitive impairment and mild dementia through basic and instrumental activities of daily living: Development of a new evaluation tool.

Authors:  Elise Cornelis; Ellen Gorus; Ingo Beyer; Ivan Bautmans; Patricia De Vriendt
Journal:  PLoS Med       Date:  2017-03-14       Impact factor: 11.069

7.  The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression.

Authors:  Hartmut Lehfeld; Mark Stemmler
Journal:  Diagnostics (Basel)       Date:  2019-10-25

8.  Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer's disease: a preliminary study.

Authors:  Yoshiaki Tsuruoka; Michio Takahashi; Masatoshi Suzuki; Koichi Sato; Yukihiko Shirayama
Journal:  Ann Gen Psychiatry       Date:  2016-01-20       Impact factor: 3.455

9.  Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.

Authors:  Stefan Klöppel; Maria Kotschi; Jessica Peter; Karl Egger; Lucrezia Hausner; Lutz Frölich; Alex Förster; Bernhard Heimbach; Claus Normann; Werner Vach; Horst Urbach; Ahmed Abdulkadir
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  On the conundrum of cognitive impairment due to depressive disorder in older patients.

Authors:  Claudia E Lanza; Karolina Sejunaite; Charlotte Steindel; Ingo Scholz; Matthias W Riepe
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.